GleamWall
中文EN

VERU VERU INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 863894 · Fiscal year ends 09/30

Financial factors as of 2024-09-30 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.6%
TTM net income YoY59.4%
TTM EPS YoY—
Revenue 3-yr CAGR-34.9%
Net income 3-yr CAGR—

Margins

Gross margin34.7%
Operating margin-214.2%
Net margin-223.9%
FCF margin-129.3%
EBITDA margin-213.0%

Returns

ROE-145.4%
ROA-68.5%
ROIC (approx.)-327.4%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets46.5%
Debt / equity0.00x
Current ratio2.97x
Interest coverage-59.54x

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-29.2%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue—$16.89M
Cost of revenue—$11.03M
Gross profit—$5.85M
R&D expense$15.59M$12.78M
SG&A expense$19.94M$24.61M
Operating income-$24.75M-$36.17M
Interest expense—$607,470
Income tax$0$0
Net income-$22.73M-$37.80M
EBITDA-$24.60M-$35.90M
EPS (basic)-1.55-2.80
EPS (diluted)——
Balance sheet
Cash & equivalents$15.79M$24.92M
Receivables—$3.96M
Inventory—$4.14M
Current assets$18.92M$35.22M
PP&E, net$364,808$481,372
Goodwill$6.88M$6.88M
Intangibles—$0
Total assets$29.84M$60.42M
Current liabilities$7.79M$11.87M
Total liabilities$11.50M$28.10M
Shareholders' equity$18.33M$32.32M
Shares outstanding14.65M14.64M
Cash flow statement
Operating cash flow-$30.04M-$21.68M
Capital expenditure$1,083$158,322
Free cash flow-$30.04M-$21.84M
Investing cash flow$25.14M$146,214
Financing cash flow-$4.22M$36.83M
Depreciation & amortization$152,105$268,177
Stock-based compensation$8.10M$13.64M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.